Augusto Consoli

Specialization: Psychiatrist
41 years of experience
Speaks:
English, Italian
Online consultations: available
Workplace: Italy, Bologna, Lucia Magnani Health Clinic
Key contributor to the LEVOPROACT study on levomethadone.
The doctor specializes in psychotherapy with a focus on opioid addiction treatment. A key contributor to a prospective study on levomethadone, the doctor has played a significant role in advancing the understanding of its safety and effectiveness for opioid maintenance treatment. The study, known as LEVOPROACT, involved collaboration with multiple centers across Italy and included contributions to study design, data collection, and manuscript preparation. Preliminary findings highlighted a favorable risk/benefit ratio for levomethadone, particularly in its impact on the QT interval and its effectiveness in reducing cravings and opioid use.

Online consultation with Augusto Consoli

Convenient and easy

100% secure and confidential

Price on request

Doctor's services

How are we doing?

1 of 3

Information about this doctor is full and clear

Strongly disagree

Strongly agree

Qualifications

Dr. Augusto Consoli has demonstrated his dedication and expertise in the field of Psychotherapy, with a particular focus on opioid addiction treatment. His significant contribution to a prospective study on the safety and effectiveness of levomethadone showcases his commitment to advancing medical knowledge and patient care.

Research Contributions

Played a crucial role in an observational, prospective study focusing on the safety and effectiveness of levomethadone in subjects undergoing opioid maintenance treatment (LEVOPROACT study).
Contributed to the study design, data collection, and interpretation.
Participated in manuscript writing, editing, and approval for submission.
Collaborated with principal investigators from various participant centers across Italy.

Study Findings

The study evaluated the safety profile of levomethadone, particularly its effects on the QT interval on an electrocardiogram, and its effectiveness in reducing craving and opioid use.
The interim analysis of the study yielded encouraging preliminary results, showing effectiveness of treatment with a favorable risk/benefit ratio for levomethadone therapy.